PVH
CORT icon

Psagot Value Holdings’s Corcept Therapeutics CORT Stock Holding History

Psagot Value Holdings’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,148
Closed -$19K – 402
2020
Q2 		$19K Sell
1,148
-1,248
-52% -$17.5K ﹤0.01% 336
2020
Q1 		$28K Buy
2,396
+1,296
+118% +$16K ﹤0.01% 325
2019
Q4 		$13K Buy
+1,100
New +$15.3K ﹤0.01% 397

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Psagot Value Holdings's CORT Position: Q3 2020 in Review

Psagot Value Holdings sold out of Corcept Therapeutics (CORT) in Q3 2020, closing a stake of 1,148 shares — an estimated $19K sold.

Psagot Value Holdings first reported a position in CORT in Q4 2019 and held it in 3 quarters. The position peaked at $28K in Q1 2020. 223 funds tracked by Wall St. Rank hold CORT as of Q3 2020.

  • Psagot Value Holdings reported no remaining Corcept Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Psagot Value Holdings sold 1,148 Corcept Therapeutics shares in Q3 2020, an estimated $19K.
  • Psagot Value Holdings first reported a position in Corcept Therapeutics in Q4 2019 and held it in 3 quarters.
  • Psagot Value Holdings's Corcept Therapeutics position peaked at $28K in Q1 2020.
  • 223 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2020.

Based on Psagot Value Holdings's 13F filing for Q3 2020, filed 27 Oct 2020.